Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05168800 · ClinicalTrials.gov registry record · NA
CONFIDENT: Supporting Long-term Care Workers During COVID-19
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2,634
- Enrollment target
NCT05168800: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT05168800 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 2,634 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05168800, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,634 participants
- Enrollment target
Study Summary
The CONFIDENT Study is an online three-arm randomized trial that aims to help long-term care workers in the United States feel more confident about the Coronavirus Disease 2019 (COVID-19) vaccines. The study will compare two different interventions to usual online information (website of the Centers for Disease Control and Prevention). The first intervention is a Dialogue-Based Webinar where people can interact and ask questions about the vaccines. The second intervention is a Social Media Website that will feature curated content about the vaccines from popular social media platforms. Participants will be asked to completed four online surveys. The first survey will be completed pre-intervention and immediately upon study enrollment (Time 0). Participants will be randomized to a trial arm at the end of the Time 0 survey. Intervention follow-up surveys will be completed 3 weeks post-randomization (Time 1), three months post-randomization (Time 2), and 6 months post-randomization (Time 3).
Primary Outcome
Confidence in the COVID-19 vaccines, assessed using the 3-item Vaccine Confidence Index (Larson et al., 2016) adapted for COVID-19. Each item is rated on a 5-point scale ranging from 1 ('Strongly disagree') to 5 ('Strongly agree'). Respondents are considered 'confident' (score of '1') if they respond 'Agree' or 'Strongly agree' on all three items and 'not confident' (score of '0') if one or more item responses is not 'Agree' or 'Strongly agree'.
Interventions
- BEHAVIORAL Dialogue-Based Webinar
- BEHAVIORAL Social Media Website
- OTHER Enhanced Usual Practice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,634 participants |
| Start Date | 2022-02-21 |
| Est. Completion | 2023-09-20 |
| Phase | NA |
What the finished NCT05168800 record still lists
NCT05168800 is an interventional study that assigns participants to a tested intervention. Its 2,634 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% higher).
The record links to 0 conditions, and to 3 interventions - of which Dialogue-Based Webinar is the first listed.
NCT05168800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05168800 about?
NCT05168800 is a clinical study titled "CONFIDENT: Supporting Long-term Care Workers During COVID-19". The CONFIDENT Study is an online three-arm randomized trial that aims to help long-term care workers in the United States feel more confident about the Coronavirus Disease 2019 (COVID-19) vaccines. The study will compare two different interventions to usual online information (website of the Centers...
What is the current status of trial NCT05168800?
This trial is currently completed. It is a NA study. The enrollment target is 2,634 participants. The study started on 2022-02-21. Estimated completion is 2023-09-20.
What interventions are being tested in trial NCT05168800?
The interventions under investigation include: Dialogue-Based Webinar (BEHAVIORAL), Social Media Website (BEHAVIORAL), Enhanced Usual Practice (OTHER).
Who is sponsoring clinical trial NCT05168800?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05168800's enrollment target sits among peer trials
2,634 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI